Search by Drug Name or NDC

    NDC 00093-8034-01 Glyburide 1.5 mg/1 Details

    Glyburide 1.5 mg/1

    Glyburide is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Teva Pharmaceuticals USA, Inc.. The primary component is GLYBURIDE.

    Product Information

    NDC 00093-8034
    Product ID 0093-8034_00e55b1b-81b5-4df1-8a6d-4d54ac403e76
    Associated GPIs 27200040100310
    GCN Sequence Number 016665
    GCN Sequence Number Description glyburide,micronized TABLET 1.5 MG ORAL
    HIC3 C4K
    HIC3 Description ANTIHYPERGLYCEMIC, INSULIN-RELEASE STIMULANT TYPE
    GCN 05713
    HICL Sequence Number 012257
    HICL Sequence Number Description GLYBURIDE,MICRONIZED
    Brand/Generic Generic
    Proprietary Name Glyburide
    Proprietary Name Suffix n/a
    Non-Proprietary Name Glyburide
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 1.5
    Active Ingredient Units mg/1
    Substance Name GLYBURIDE
    Labeler Name Teva Pharmaceuticals USA, Inc.
    Pharmaceutical Class Sulfonylurea Compounds [CS], Sulfonylurea [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA074686
    Listing Certified Through 2024-12-31

    Package

    NDC 00093-8034-01 (00093803401)

    NDC Package Code 0093-8034-01
    Billing NDC 00093803401
    Package 100 TABLET in 1 BOTTLE (0093-8034-01)
    Marketing Start Date 1999-05-11
    NDC Exclude Flag N
    Pricing Information N/A